Moderate amounts of caffeine drank regularly could help to protect against multiple cardiometabolic diseases including type 2 diabetes, coronary heart disease and stroke, research has indicated.

The team behind the study say that drinking around three cups of coffee a day could reduce the risk of a person developing cardiometabolic diseases.

Cardiometabolic multimorbidity (CM), which is when someone has at least two cardiometabolic diseases, is growing in prevalence and is a concern to health chiefs around the world due to aging populations.

This latest research has found that regular, moderate amounts of caffeine is linked to a lower risk of CM.

People who drink around three cups of 200mg to 300mg caffeine a day had the lowest risk of new-onset CM at 40.7%, compared to people who do not drink any caffeine and those who consume less than 100mg a day, who had a 48.1% risk.

Researchers from Suzhou Medical College of Soochow University in China examined data from more than 500,000 people in the UK aged between 37 and 73.

This included just over 172,300 people with no cardiometabolic diseases for caffeine consumption analysis and a further 188,091 people for analysis of tea and coffee consumption.

Self-reported medical conditions, hospital data and death registry records were used to collect data on cardiometabolic diseases outcomes.

Consumption of caffeine at all levels were inversely linked to risk of new-onset CM in those who did not have cardiometabolic diseases.

Lead author Chaofu Ke said: “Consuming three cups of coffee, or 200–300 mg caffeine, per day might help to reduce the risk of developing cardiometabolic multimorbidity in individuals without any cardiometabolic disease.

“The findings highlight that promoting moderate amounts of coffee or caffeine intake as a dietary habit for healthy people might have far-reaching benefits for the prevention of CM.”

Their research found that people with just one cardiometabolic disease could have a two-fold higher risk of all-cause mortality than those with no cardiometabolic disease.

The risk of all-cause mortality is almost four to seven-times higher in people with CM.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.